Armistice Capital, LLC Bionomics Limited Transaction History
Armistice Capital, LLC
- $7.69 Billion
- Q2 2024
A detailed history of Armistice Capital, LLC transactions in Bionomics Limited stock. As of the latest transaction made, Armistice Capital, LLC holds 1,226,759 shares of BNOX stock, worth $650,182. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,226,759Holding current value
$650,182% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BNOX
# of Institutions
12Shares Held
1.64MCall Options Held
0Put Options Held
0-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct316KShares$167,4800.0% of portfolio
-
Ubs Group Ag34.9KShares$18,4950.0% of portfolio
-
Two Sigma Securities, LLC New York, NY26KShares$13,8000.0% of portfolio
-
Two Sigma Investments, LP New York, NY16.4KShares$8,6760.0% of portfolio
-
Xtx Topco LTD London, X010.9KShares$5,7980.0% of portfolio
About BIONOMICS LIMITED
- Ticker BNOX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,518,620
- Market Cap $3.98M
- Description
- Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has ...